The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Psilocybin Assisted Therapy Market Research Report 2025
Synopsis
The global Psilocybin Assisted Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Psilocybin Assisted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psilocybin Assisted Therapy.
Report Scope
The Psilocybin Assisted Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Psilocybin Assisted Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psilocybin Assisted Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MindMed
Compass Pathways
ATAI Life Sciences
Field Trip
DemeRx
Eleusis
Hikma Pharmaceuticals PLC
Pfizer
Verrian
Jazz Pharmaceuticals
Segment by Type
Natural
Synthetic
Segment by Application
Cluster Headaches
Anxiety Disorders
Psychiatric Disorders
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Psilocybin Assisted Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Psilocybin Assisted Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Psilocybin Assisted Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Psilocybin Assisted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psilocybin Assisted Therapy.
Report Scope
The Psilocybin Assisted Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Psilocybin Assisted Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psilocybin Assisted Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MindMed
Compass Pathways
ATAI Life Sciences
Field Trip
DemeRx
Eleusis
Hikma Pharmaceuticals PLC
Pfizer
Verrian
Jazz Pharmaceuticals
Segment by Type
Natural
Synthetic
Segment by Application
Cluster Headaches
Anxiety Disorders
Psychiatric Disorders
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Psilocybin Assisted Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Psilocybin Assisted Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Psilocybin Assisted Therapy Market Overview
1.1 Product Overview and Scope of Psilocybin Assisted Therapy
1.2 Psilocybin Assisted Therapy Segment by Type
1.2.1 Global Psilocybin Assisted Therapy Market Value Comparison by Type (2024-2030)
1.2.2 Natural
1.2.3 Synthetic
1.3 Psilocybin Assisted Therapy Segment by Application
1.3.1 Global Psilocybin Assisted Therapy Market Value by Application: (2024-2030)
1.3.2 Cluster Headaches
1.3.3 Anxiety Disorders
1.3.4 Psychiatric Disorders
1.4 Global Psilocybin Assisted Therapy Market Size Estimates and Forecasts
1.4.1 Global Psilocybin Assisted Therapy Revenue 2019-2030
1.4.2 Global Psilocybin Assisted Therapy Sales 2019-2030
1.4.3 Global Psilocybin Assisted Therapy Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Psilocybin Assisted Therapy Market Competition by Manufacturers
2.1 Global Psilocybin Assisted Therapy Sales Market Share by Manufacturers (2019-2024)
2.2 Global Psilocybin Assisted Therapy Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Psilocybin Assisted Therapy Average Price by Manufacturers (2019-2024)
2.4 Global Psilocybin Assisted Therapy Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Psilocybin Assisted Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Psilocybin Assisted Therapy, Product Type & Application
2.7 Psilocybin Assisted Therapy Market Competitive Situation and Trends
2.7.1 Psilocybin Assisted Therapy Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Psilocybin Assisted Therapy Players Market Share by Revenue
2.7.3 Global Psilocybin Assisted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Psilocybin Assisted Therapy Retrospective Market Scenario by Region
3.1 Global Psilocybin Assisted Therapy Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Psilocybin Assisted Therapy Global Psilocybin Assisted Therapy Sales by Region: 2019-2030
3.2.1 Global Psilocybin Assisted Therapy Sales by Region: 2019-2024
3.2.2 Global Psilocybin Assisted Therapy Sales by Region: 2025-2030
3.3 Global Psilocybin Assisted Therapy Global Psilocybin Assisted Therapy Revenue by Region: 2019-2030
3.3.1 Global Psilocybin Assisted Therapy Revenue by Region: 2019-2024
3.3.2 Global Psilocybin Assisted Therapy Revenue by Region: 2025-2030
3.4 North America Psilocybin Assisted Therapy Market Facts & Figures by Country
3.4.1 North America Psilocybin Assisted Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Psilocybin Assisted Therapy Sales by Country (2019-2030)
3.4.3 North America Psilocybin Assisted Therapy Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Psilocybin Assisted Therapy Market Facts & Figures by Country
3.5.1 Europe Psilocybin Assisted Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Psilocybin Assisted Therapy Sales by Country (2019-2030)
3.5.3 Europe Psilocybin Assisted Therapy Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Psilocybin Assisted Therapy Market Facts & Figures by Country
3.6.1 Asia Pacific Psilocybin Assisted Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Psilocybin Assisted Therapy Sales by Country (2019-2030)
3.6.3 Asia Pacific Psilocybin Assisted Therapy Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Psilocybin Assisted Therapy Market Facts & Figures by Country
3.7.1 Latin America Psilocybin Assisted Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Psilocybin Assisted Therapy Sales by Country (2019-2030)
3.7.3 Latin America Psilocybin Assisted Therapy Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Psilocybin Assisted Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa Psilocybin Assisted Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Psilocybin Assisted Therapy Sales by Country (2019-2030)
3.8.3 Middle East and Africa Psilocybin Assisted Therapy Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Psilocybin Assisted Therapy Sales by Type (2019-2030)
4.1.1 Global Psilocybin Assisted Therapy Sales by Type (2019-2024)
4.1.2 Global Psilocybin Assisted Therapy Sales by Type (2025-2030)
4.1.3 Global Psilocybin Assisted Therapy Sales Market Share by Type (2019-2030)
4.2 Global Psilocybin Assisted Therapy Revenue by Type (2019-2030)
4.2.1 Global Psilocybin Assisted Therapy Revenue by Type (2019-2024)
4.2.2 Global Psilocybin Assisted Therapy Revenue by Type (2025-2030)
4.2.3 Global Psilocybin Assisted Therapy Revenue Market Share by Type (2019-2030)
4.3 Global Psilocybin Assisted Therapy Price by Type (2019-2030)
5 Segment by Application
5.1 Global Psilocybin Assisted Therapy Sales by Application (2019-2030)
5.1.1 Global Psilocybin Assisted Therapy Sales by Application (2019-2024)
5.1.2 Global Psilocybin Assisted Therapy Sales by Application (2025-2030)
5.1.3 Global Psilocybin Assisted Therapy Sales Market Share by Application (2019-2030)
5.2 Global Psilocybin Assisted Therapy Revenue by Application (2019-2030)
5.2.1 Global Psilocybin Assisted Therapy Revenue by Application (2019-2024)
5.2.2 Global Psilocybin Assisted Therapy Revenue by Application (2025-2030)
5.2.3 Global Psilocybin Assisted Therapy Revenue Market Share by Application (2019-2030)
5.3 Global Psilocybin Assisted Therapy Price by Application (2019-2030)
6 Key Companies Profiled
6.1 MindMed
6.1.1 MindMed Corporation Information
6.1.2 MindMed Description and Business Overview
6.1.3 MindMed Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2019-2024)
6.1.4 MindMed Psilocybin Assisted Therapy Product Portfolio
6.1.5 MindMed Recent Developments/Updates
6.2 Compass Pathways
6.2.1 Compass Pathways Corporation Information
6.2.2 Compass Pathways Description and Business Overview
6.2.3 Compass Pathways Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Compass Pathways Psilocybin Assisted Therapy Product Portfolio
6.2.5 Compass Pathways Recent Developments/Updates
6.3 ATAI Life Sciences
6.3.1 ATAI Life Sciences Corporation Information
6.3.2 ATAI Life Sciences Description and Business Overview
6.3.3 ATAI Life Sciences Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2019-2024)
6.3.4 ATAI Life Sciences Psilocybin Assisted Therapy Product Portfolio
6.3.5 ATAI Life Sciences Recent Developments/Updates
6.4 Field Trip
6.4.1 Field Trip Corporation Information
6.4.2 Field Trip Description and Business Overview
6.4.3 Field Trip Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Field Trip Psilocybin Assisted Therapy Product Portfolio
6.4.5 Field Trip Recent Developments/Updates
6.5 DemeRx
6.5.1 DemeRx Corporation Information
6.5.2 DemeRx Description and Business Overview
6.5.3 DemeRx Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2019-2024)
6.5.4 DemeRx Psilocybin Assisted Therapy Product Portfolio
6.5.5 DemeRx Recent Developments/Updates
6.6 Eleusis
6.6.1 Eleusis Corporation Information
6.6.2 Eleusis Description and Business Overview
6.6.3 Eleusis Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Eleusis Psilocybin Assisted Therapy Product Portfolio
6.6.5 Eleusis Recent Developments/Updates
6.7 Hikma Pharmaceuticals PLC
6.6.1 Hikma Pharmaceuticals PLC Corporation Information
6.6.2 Hikma Pharmaceuticals PLC Description and Business Overview
6.6.3 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Portfolio
6.7.5 Hikma Pharmaceuticals PLC Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer Psilocybin Assisted Therapy Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Verrian
6.9.1 Verrian Corporation Information
6.9.2 Verrian Description and Business Overview
6.9.3 Verrian Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Verrian Psilocybin Assisted Therapy Product Portfolio
6.9.5 Verrian Recent Developments/Updates
6.10 Jazz Pharmaceuticals
6.10.1 Jazz Pharmaceuticals Corporation Information
6.10.2 Jazz Pharmaceuticals Description and Business Overview
6.10.3 Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Portfolio
6.10.5 Jazz Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Psilocybin Assisted Therapy Industry Chain Analysis
7.2 Psilocybin Assisted Therapy Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Psilocybin Assisted Therapy Production Mode & Process
7.4 Psilocybin Assisted Therapy Sales and Marketing
7.4.1 Psilocybin Assisted Therapy Sales Channels
7.4.2 Psilocybin Assisted Therapy Distributors
7.5 Psilocybin Assisted Therapy Customers
8 Psilocybin Assisted Therapy Market Dynamics
8.1 Psilocybin Assisted Therapy Industry Trends
8.2 Psilocybin Assisted Therapy Market Drivers
8.3 Psilocybin Assisted Therapy Market Challenges
8.4 Psilocybin Assisted Therapy Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Psilocybin Assisted Therapy Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Psilocybin Assisted Therapy Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Psilocybin Assisted Therapy Market Competitive Situation by Manufacturers in 2023
Table 4. Global Psilocybin Assisted Therapy Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Psilocybin Assisted Therapy Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Psilocybin Assisted Therapy Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Psilocybin Assisted Therapy Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Psilocybin Assisted Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Psilocybin Assisted Therapy, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Psilocybin Assisted Therapy, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Psilocybin Assisted Therapy, Product Type & Application
Table 12. Global Key Manufacturers of Psilocybin Assisted Therapy, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Psilocybin Assisted Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psilocybin Assisted Therapy as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Psilocybin Assisted Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Psilocybin Assisted Therapy Sales by Region (2019-2024) & (K Units)
Table 18. Global Psilocybin Assisted Therapy Sales Market Share by Region (2019-2024)
Table 19. Global Psilocybin Assisted Therapy Sales by Region (2025-2030) & (K Units)
Table 20. Global Psilocybin Assisted Therapy Sales Market Share by Region (2025-2030)
Table 21. Global Psilocybin Assisted Therapy Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Psilocybin Assisted Therapy Revenue Market Share by Region (2019-2024)
Table 23. Global Psilocybin Assisted Therapy Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Psilocybin Assisted Therapy Revenue Market Share by Region (2025-2030)
Table 25. North America Psilocybin Assisted Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Psilocybin Assisted Therapy Sales by Country (2019-2024) & (K Units)
Table 27. North America Psilocybin Assisted Therapy Sales by Country (2025-2030) & (K Units)
Table 28. North America Psilocybin Assisted Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Psilocybin Assisted Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Psilocybin Assisted Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Psilocybin Assisted Therapy Sales by Country (2019-2024) & (K Units)
Table 32. Europe Psilocybin Assisted Therapy Sales by Country (2025-2030) & (K Units)
Table 33. Europe Psilocybin Assisted Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Psilocybin Assisted Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Psilocybin Assisted Therapy Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Psilocybin Assisted Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Psilocybin Assisted Therapy Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Psilocybin Assisted Therapy Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Psilocybin Assisted Therapy Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Psilocybin Assisted Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Psilocybin Assisted Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Psilocybin Assisted Therapy Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Psilocybin Assisted Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Psilocybin Assisted Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Psilocybin Assisted Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Psilocybin Assisted Therapy Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Psilocybin Assisted Therapy Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Psilocybin Assisted Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Psilocybin Assisted Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Psilocybin Assisted Therapy Sales (K Units) by Type (2019-2024)
Table 51. Global Psilocybin Assisted Therapy Sales (K Units) by Type (2025-2030)
Table 52. Global Psilocybin Assisted Therapy Sales Market Share by Type (2019-2024)
Table 53. Global Psilocybin Assisted Therapy Sales Market Share by Type (2025-2030)
Table 54. Global Psilocybin Assisted Therapy Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Psilocybin Assisted Therapy Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Psilocybin Assisted Therapy Revenue Market Share by Type (2019-2024)
Table 57. Global Psilocybin Assisted Therapy Revenue Market Share by Type (2025-2030)
Table 58. Global Psilocybin Assisted Therapy Price (USD/Unit) by Type (2019-2024)
Table 59. Global Psilocybin Assisted Therapy Price (USD/Unit) by Type (2025-2030)
Table 60. Global Psilocybin Assisted Therapy Sales (K Units) by Application (2019-2024)
Table 61. Global Psilocybin Assisted Therapy Sales (K Units) by Application (2025-2030)
Table 62. Global Psilocybin Assisted Therapy Sales Market Share by Application (2019-2024)
Table 63. Global Psilocybin Assisted Therapy Sales Market Share by Application (2025-2030)
Table 64. Global Psilocybin Assisted Therapy Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Psilocybin Assisted Therapy Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Psilocybin Assisted Therapy Revenue Market Share by Application (2019-2024)
Table 67. Global Psilocybin Assisted Therapy Revenue Market Share by Application (2025-2030)
Table 68. Global Psilocybin Assisted Therapy Price (USD/Unit) by Application (2019-2024)
Table 69. Global Psilocybin Assisted Therapy Price (USD/Unit) by Application (2025-2030)
Table 70. MindMed Corporation Information
Table 71. MindMed Description and Business Overview
Table 72. MindMed Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. MindMed Psilocybin Assisted Therapy Product
Table 74. MindMed Recent Developments/Updates
Table 75. Compass Pathways Corporation Information
Table 76. Compass Pathways Description and Business Overview
Table 77. Compass Pathways Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Compass Pathways Psilocybin Assisted Therapy Product
Table 79. Compass Pathways Recent Developments/Updates
Table 80. ATAI Life Sciences Corporation Information
Table 81. ATAI Life Sciences Description and Business Overview
Table 82. ATAI Life Sciences Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. ATAI Life Sciences Psilocybin Assisted Therapy Product
Table 84. ATAI Life Sciences Recent Developments/Updates
Table 85. Field Trip Corporation Information
Table 86. Field Trip Description and Business Overview
Table 87. Field Trip Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Field Trip Psilocybin Assisted Therapy Product
Table 89. Field Trip Recent Developments/Updates
Table 90. DemeRx Corporation Information
Table 91. DemeRx Description and Business Overview
Table 92. DemeRx Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. DemeRx Psilocybin Assisted Therapy Product
Table 94. DemeRx Recent Developments/Updates
Table 95. Eleusis Corporation Information
Table 96. Eleusis Description and Business Overview
Table 97. Eleusis Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Eleusis Psilocybin Assisted Therapy Product
Table 99. Eleusis Recent Developments/Updates
Table 100. Hikma Pharmaceuticals PLC Corporation Information
Table 101. Hikma Pharmaceuticals PLC Description and Business Overview
Table 102. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product
Table 104. Hikma Pharmaceuticals PLC Recent Developments/Updates
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Pfizer Psilocybin Assisted Therapy Product
Table 109. Pfizer Recent Developments/Updates
Table 110. Verrian Corporation Information
Table 111. Verrian Description and Business Overview
Table 112. Verrian Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Verrian Psilocybin Assisted Therapy Product
Table 114. Verrian Recent Developments/Updates
Table 115. Jazz Pharmaceuticals Corporation Information
Table 116. Jazz Pharmaceuticals Description and Business Overview
Table 117. Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Jazz Pharmaceuticals Psilocybin Assisted Therapy Product
Table 119. Jazz Pharmaceuticals Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Psilocybin Assisted Therapy Distributors List
Table 123. Psilocybin Assisted Therapy Customers List
Table 124. Psilocybin Assisted Therapy Market Trends
Table 125. Psilocybin Assisted Therapy Market Drivers
Table 126. Psilocybin Assisted Therapy Market Challenges
Table 127. Psilocybin Assisted Therapy Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Psilocybin Assisted Therapy
Figure 2. Global Psilocybin Assisted Therapy Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Psilocybin Assisted Therapy Market Share by Type in 2023 & 2030
Figure 4. Natural Product Picture
Figure 5. Synthetic Product Picture
Figure 6. Global Psilocybin Assisted Therapy Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Psilocybin Assisted Therapy Market Share by Application in 2023 & 2030
Figure 8. Cluster Headaches
Figure 9. Anxiety Disorders
Figure 10. Psychiatric Disorders
Figure 11. Global Psilocybin Assisted Therapy Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Psilocybin Assisted Therapy Market Size (2019-2030) & (US$ Million)
Figure 13. Global Psilocybin Assisted Therapy Sales (2019-2030) & (K Units)
Figure 14. Global Psilocybin Assisted Therapy Average Price (USD/Unit) & (2019-2030)
Figure 15. Psilocybin Assisted Therapy Report Years Considered
Figure 16. Psilocybin Assisted Therapy Sales Share by Manufacturers in 2023
Figure 17. Global Psilocybin Assisted Therapy Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Psilocybin Assisted Therapy Players: Market Share by Revenue in 2023
Figure 19. Psilocybin Assisted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Psilocybin Assisted Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Psilocybin Assisted Therapy Sales Market Share by Country (2019-2030)
Figure 22. North America Psilocybin Assisted Therapy Revenue Market Share by Country (2019-2030)
Figure 23. United States Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Psilocybin Assisted Therapy Sales Market Share by Country (2019-2030)
Figure 26. Europe Psilocybin Assisted Therapy Revenue Market Share by Country (2019-2030)
Figure 27. Germany Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Psilocybin Assisted Therapy Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Psilocybin Assisted Therapy Revenue Market Share by Region (2019-2030)
Figure 34. China Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Psilocybin Assisted Therapy Sales Market Share by Country (2019-2030)
Figure 44. Latin America Psilocybin Assisted Therapy Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Psilocybin Assisted Therapy Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Psilocybin Assisted Therapy Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Psilocybin Assisted Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Psilocybin Assisted Therapy by Type (2019-2030)
Figure 54. Global Revenue Market Share of Psilocybin Assisted Therapy by Type (2019-2030)
Figure 55. Global Psilocybin Assisted Therapy Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Psilocybin Assisted Therapy by Application (2019-2030)
Figure 57. Global Revenue Market Share of Psilocybin Assisted Therapy by Application (2019-2030)
Figure 58. Global Psilocybin Assisted Therapy Price (USD/Unit) by Application (2019-2030)
Figure 59. Psilocybin Assisted Therapy Value Chain
Figure 60. Psilocybin Assisted Therapy Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
